Search Results for keywords:"Department of Health and Human Services"

The Advisory Committee on Childhood Vaccines (ACCV), part of the Health Resources and Services Administration within the Department of Health and Human Services, has announced plans for public meetings throughout 2021. These meetings will occur on four dates: March 4, June 3, September 2, and December 2, all running from 10:00 a.m. to 4:00 p.m. Eastern Time. The meetings may be held in person in Rockville, Maryland, or via teleconference and webinar, and the public is invited to participate. The ACCV advises on the National Vaccine Injury Compensation Program and related issues, and attendees are encouraged to submit comments or questions in advance.

The Department of Health and Human Services has renewed the charter for the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) as announced by the Health Resources and Services Administration (HRSA). This renewal allows the council to continue its operations until February 19, 2027, where it will advise on matters related to blood stem cell transplantation, including the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory. ACBSCT provides expert recommendations on stem cell science and potential therapies. The renewal was effective as of February 19, 2025, and details can be accessed online through the council's website or the FACA database.

The Department of Health and Human Services (HHS) has released a notice which informs federal agencies about the laboratories and facilities certified to conduct drug testing using urine and oral fluid as per the Mandatory Guidelines for Federal Workplace Drug Testing Programs. As of now, there are no labs certified for oral fluid testing, but several are certified for urine testing, including those in Canada, which are overseen by the standards of the Department of Transportation (DOT). The list includes details about each certified laboratory and highlights a facility that is withdrawing from the certification program.

The Indian Health Service (IHS), part of the Department of Health and Human Services (HHS), has reorganized its structure, particularly focusing on its Office of Quality. This reorganization aims to enhance the functions of the IHS in areas such as legislative affairs, quality improvement, patient safety, risk management, and compliance. Key divisions under the Office of Quality now include the Division of Quality Assurance and Patient Safety, Division of Enterprise Risk Management, Division of Innovation and Improvement, and Division of Compliance, each with specific roles to improve health outcomes and operational standards within the IHS. Roselyn Tso, the Director of IHS, has confirmed that all prior delegations of authority remain effective unless changed by the reorganization.

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, is awarding around $20 million to the World Health Organization (WHO), with the total expected funding to reach approximately $100 million over five years. This funding will help CDC and WHO work together to improve the world's ability to detect, respond to, and prevent infectious diseases. The focus is on building infrastructure and preparing for disease outbreaks, using WHO's global network to support these efforts. The award period is from September 2025 to September 2030.

The document is a notice from the Department of Health and Human Services (HHS) that updates the organization and structure of its Office of the General Counsel (OGC). The OGC provides legal services and advice to various entities within the HHS, including the Secretary, on a wide range of issues. It is organized into several divisions, each specializing in different areas such as ethics, civil rights, and public health, and it has regional offices throughout the United States. This updated statement outlines the responsibilities and hierarchy within the OGC, ensuring uniform legal advice and services across the department.

The Department of Health and Human Services' Office of the Secretary is asking for public comments on a proposed information collection. This request is made under the Paperwork Reduction Act of 1995 and aims to gather qualitative feedback about the agency's service delivery. The feedback will focus on various aspects like timeliness, accuracy, and efficiency of services. Comments must be submitted by April 23, 2021.

The Department of Health and Human Services (HHS) published a final rule concerning a new Privacy Act system of records called "NIH Police Records" maintained by the National Institutes of Health (NIH). Originally scheduled to take effect on February 18, 2025, this rule's start date is now delayed until March 21, 2025. The delay follows a memorandum from President Trump titled "Regulatory Freeze Pending Review," which suggested postponing the implementation of such rules for 60 days to allow for further review. The shift aims to ensure a comprehensive consideration of the rule's impact.

The National Institutes of Health, under the Department of Health and Human Services, has scheduled two upcoming closed meetings by the National Institute of Nursing Research. These meetings, taking place virtually from Bethesda, MD on February 5 and February 19, 2021, will focus on reviewing and evaluating grant applications. The purpose of closing the meetings is to protect confidential trade secrets, commercial property, and personal information related to the applications. Ming Yan, a Scientific Review Officer, is the contact person for these sessions.

The Health Resources and Services Administration (HRSA) of the Department of Health and Human Services is seeking public comments on a proposed data collection project related to the Small Health Care Provider Quality Improvement Program. This project aims to support rural health care providers in implementing quality improvement activities using health information technology to enhance care and patient outcomes. Comments on the Information Collection Request (ICR) should be submitted by April 26, 2021, and HRSA is particularly interested in feedback on the utility of the data collection, its burden estimation, and suggestions for improving the process.